Delivery Order SPE2DB20D1004-SPE2DB24FF9S2

Award Date 5/6/24
Potential Completion Date 5/7/24
Potential Value $8.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products to the U.S. Defense Logistics Agency (DLA). The single-award Indefinite Delivery Contract (IDC) is valued up to $999,999,999.00 and runs through December 31, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department of Veterans Affairs...
This federal contract award is for the delivery of pharmaceutical products, specifically Trelegy Ellipta 100-62.5-25 60S, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $2,874.69. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC is valued at up to...
This federal contract award is for the delivery of medical products, specifically TRELEGY ELLIPTA 200-62.5-25 60S, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., as a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. This IDC, which runs through November 2026, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The award is for the supply of Trelegy Ellipta 100-62.5-25 60S, a respiratory medication, with a ceiling value of $2,407.09 and an ultimate completion date of April 26, 2022. The contract is a firm fixed-price arrangement and does not have a set-aside...
This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The award, with a ceiling value of $3,205.57, was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has an ultimate completion date of April 3, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp holds...
This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $10,800.64. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support...
This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $11,783.89 and an ultimate completion date of November 16, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA...
This federal contract award is for the delivery of the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $2,008.68 and is a firm fixed-price delivery order with an ultimate completion date of August 4, 2021. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $11,216.56, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves...
This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,974.54 delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on November 6, 2023 with a completion date of November 7, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This single-award IDC...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FF9S2
    Delivery Order

This federal contract award is for the delivery of the pharmaceutical product Trelegy Ellipta 100-62.5-25 60s to the Defense Logistics Agency (DLA). The single-award Indefinite Delivery Contract (IDC), valued at up to $999,999,999.00, was issued to the prime contractor Cencora, Inc., doing business as Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract runs through December 31, 2025 and serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific delivery order, valued at $8,281.73, has a firm fixed price and a completion date of May 7, 2024. The contract was awarded on May 6, 2024 and does not have a set-aside designation, indicating full and open competition.

Generated 5/16/25, 12:23 PM